AGP Picks
View all

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on August 6, 2026

Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
The Joint Corp. Reports Second Quarter 2026 Financial Results
Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
Caring Brands Provides Intellectual Property Portfolio Update
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
SkinHealth Systems Reports Second Quarter 2026 Financial Results
Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
Health Catalyst Reports Second Quarter 2026 Results
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Voyager Reports Second Quarter 2026 Financial and Operating Results
Outset Medical Reports Second Quarter 2026 Results
Celldex Reports Second Quarter Financial Results and Provides Corporate Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.